Go to the list of all blogs
Joma Foster's Avatar
published in Blogs
Aug 13, 2026
Equinox Gold (EQX) Rises +22% in 30 Days on Gold Price Strength

Equinox Gold (EQX) Rises +22% in 30 Days on Gold Price Strength

Key Takeaways

  • EQX shares rose roughly 22% over the 30-day stretch from mid-July to mid-August 2026, moving from a July 13, 2026 close of $9.45 to about $11.55 in the latest available session.
  • The advance coincided with a sharp rebound in gold, which posted its largest one-day gain since February on August 5, 2026, and extended above $4,300 per ounce.
  • Company-specific catalysts included the completed Orla Mining merger, higher 2026 production guidance, a 50% dividend increase, and approval of the Valentine mine Phase II expansion.
  • Second-quarter revenue climbed 60.8% year over year to $769.8 million, while adjusted earnings per share came in slightly below consensus.
  • Even with the 30-day rally, the stock remains below mid-May levels; on a trailing three-month basis, shares are down about 22%.

Equinox Gold (EQX) Company Overview and Market Position

Equinox Gold Corp. is a Canadian gold mining company headquartered in Vancouver, British Columbia. The company acquires, explores, develops, and operates gold and silver properties across the Americas, with producing assets in Canada, the United States, and Mexico. Following the July 31, 2026 completion of its merger with Orla Mining, EQX positions itself as a senior North American gold producer anchored by the Greenstone, Musselwhite, and Valentine mines in Canada, with Camino Rojo in Mexico. Management's 2026 consolidated production guidance of 870,000 to 920,000 ounces, or roughly 1.1 million ounces on a pro forma basis, reflects the combined portfolio. Investors follow EQX for its leverage to gold prices, the ramp-up of newer mines, and a growth pipeline that includes the Valentine Phase II expansion and other development projects. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.

Equinox Gold (EQX) Stock Price Performance: Last 30 Days vs. Quarter

From the July 13, 2026 close of $9.45 to the latest available price around $11.55, EQX gained approximately 22.2% over the 30-day window. The move was not linear: shares slipped to a July 17 close of $8.62 before stabilizing, then accelerated in early August. Between August 4 and August 7, the stock advanced from $9.58 to $11.58, a three-session gain of roughly 21% on elevated volume. Over the trailing quarter, the picture is different. Using the May 12, 2026 close of $14.80 as the three-month reference point, EQX is still down about 22%. That reflects a steep correction through late May and June, when gold prices weakened, followed by the July-August rebound.

What Drove EQX Stock Price in the Last 30 Days

The strongest catalyst was gold itself. On August 5, spot gold jumped more than 4% to about $4,247 per ounce, its largest single-day gain since February, and extended above $4,300 in the following sessions. The move was supported by a weaker U.S. dollar, lower Treasury yields, reduced market expectations for a September Federal Reserve rate increase after a soft July ADP private payrolls report, and easing Middle East shipping tensions that pulled oil prices lower. As a high-beta gold producer, EQX magnified the move in bullion. Company fundamentals reinforced the rally. On August 5, Equinox Gold reported second-quarter revenue of $769.8 million, up 60.8% year over year, with net income attributable to common shareholders of $242.6 million and operating cash flow of $203.4 million. Adjusted EPS of $0.16 was slightly below the $0.17 consensus. Management raised 2026 production guidance to 870,000-920,000 ounces, announced a 50% dividend increase to an annualized $0.09 per share, and approved the $436 million Valentine Phase II expansion. The Orla Mining merger, completed July 31, added scale and near-term production contributions. Several brokerages reiterated Buy-equivalent ratings after the update, with published targets generally ranging from about $13 to $18. From what I see, using Tickeron’s AI Trend Prediction Engine helped confirm the alignment with broader gold sector momentum.

What Drove EQX Stock Performance Over the Last Quarter

Over the trailing quarter, EQX has been shaped by the broader gold correction and subsequent recovery. Gold fell sharply from its January record and traded near its lows in early July, pressuring miners' margins and valuations; EQX slid from about $14.80 in mid-May to the $8.60 area by mid-July. Softer bullion prices, cost inflation, and uncertainty around the Federal Reserve's rate path weighed on sentiment. The narrative began to shift in late July and early August as gold stabilized, the latest Fed decision passed, and the Orla merger closed. The combination of improving gold prices and a larger, higher-production asset base supported the rebound, even though the stock has not yet reclaimed its spring levels.

EQX Stock Forecast Drivers: What Investors Should Watch Next

Looking ahead, the key variables are gold prices and operational execution. Gold's trajectory will likely hinge on U.S. dollar moves, Treasury yields, Federal Reserve policy expectations, inflation data, and geopolitical developments in the Middle East. For Equinox Gold specifically, investors are likely to focus on the integration of the former Orla assets, Musselwhite and Camino Rojo, and whether their five-month 2026 contribution meets guidance. Valentine's grade and throughput progression, Greenstone's recovery improvements and trommel installation, and cost control will also be closely watched; the company's 2026 all-in sustaining cost guidance of $1,900 to $2,000 per ounce leaves limited room for input-cost surprises. The next quarterly report, currently estimated for early November 2026, is another major checkpoint. Market participants may also monitor dividend follow-through and updated analyst targets as the combined company reports a full quarter of merged results. I'm watching this closely as the merged operations begin to report full results.

Using AI Tools for Ongoing Research

In my regular analysis of gold equities like EQX, I find value in reviewing curated AI-driven strategies. Tickeron's Trending AI Robots page highlights top-performing bots from a wider marketplace, allowing quick identification of approaches that match different risk profiles and holding periods. It serves as a practical discovery tool for those exploring systematic methods in the sector.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: EQX

EQX in upward trend: 10-day moving average moved above 50-day moving average on August 11, 2026

The 10-day moving average for EQX crossed bullishly above the 50-day moving average on August 11, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In of 17 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on July 30, 2026. You may want to consider a long position or call options on EQX as a result. In of 88 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for EQX just turned positive on July 21, 2026. Looking at past instances where EQX's MACD turned positive, the stock continued to rise in of 50 cases over the following month. The odds of a continued upward trend are .

EQX moved above its 50-day moving average on August 05, 2026 date and that indicates a change from a downward trend to an upward trend.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where EQX advanced for three days, in of 300 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The RSI Indicator has been in the overbought zone for 2 days. Expect a price pull-back in the near future.

The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 4 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where EQX declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

EQX broke above its upper Bollinger Band on August 05, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

The Aroon Indicator for EQX entered a downward trend on July 27, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.138) is normal, around the industry mean (4.040). P/E Ratio (17.938) is within average values for comparable stocks, (50.974). EQX's Projected Growth (PEG Ratio) (0.000) is very low in comparison to the industry average of (2.505). Dividend Yield (0.003) settles around the average of (0.014) among similar stocks. P/S Ratio (3.246) is also within normal values, averaging (7.374).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. EQX’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. EQX’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 64, placing this stock worse than average.

Notable companies

The most notable companies in this group are Newmont Corp (NYSE:NEM), Wheaton Precious Metals Corp (NYSE:WPM), Gold Fields Ltd (NYSE:GFI), Kinross Gold Corp (NYSE:KGC), Pan American Silver Corp (NYSE:PAAS), SSR Mining (NASDAQ:SSRM).

Industry description

The Precious Metals industry is engaged in exploring/mining metals that are considered to be rare and/or have a high economic value. Popular precious metals include gold, platinum and silver - all three of which are largely used in jewelry, art and coinage alongwith having some industrial uses as well. Precious metals used in industrial processes include iridium, (used in specialty alloys), and palladium ( used in electronics and chemical applications). Historically, precious metals have traded at much higher prices than common industrial metals. Newmont Goldcorp Corp, Barrick Gold Corp and Freeport-McMoRan are few of the major precious metals producing companies in the U.S.

Market Cap

The average market capitalization across the Precious Metals Industry is 13.21B. The market cap for tickers in the group ranges from 575 to 134.78B. ZIJMF holds the highest valuation in this group at 134.78B. The lowest valued company is DRIFF at 575.

High and low price notable news

The average weekly price growth across all stocks in the Precious Metals Industry was 11%. For the same Industry, the average monthly price growth was 22%, and the average quarterly price growth was -17%. THM experienced the highest price growth at 49%, while ORLA experienced the biggest fall at 0%.

Volume

The average weekly volume growth across all stocks in the Precious Metals Industry was -14%. For the same stocks of the Industry, the average monthly volume growth was 61% and the average quarterly volume growth was -40%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 48
P/E Growth Rating: 76
Price Growth Rating: 48
SMR Rating: 65
Profit Risk Rating: 64
Seasonality Score: 7 (-100 ... +100)
View a ticker or compare two or three
EQX
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
A.I. Advisor
published General Information

General Information

a company, which engages in the exploration of gold mining properties

Industry PreciousMetals

Profile
Details
Industry
N/A
Address
700 West Pender Street
Phone
+1 604 558-0560
Employees
8208
Web
https://www.equinoxgold.com
Interact to see
Advertisement
Novo Nordisk (NVO) reports Q4 2025 earnings on February 4, 2026, with consensus estimates of $11.96 billion in revenue and $0.89 EPS, reflecting a moderation in GLP-1 growth. Eli Lilly (LLY) is expected to report around the same time, with projections of $17.87 billion in revenue and $6.99 EPS, driven by continued volume gains from Mounjaro and Zepbound.
Banco Santander (SAN) reports Q4 2025 earnings on February 4, 2026, following record nine-month attributable profit of €10.3 billion, up 11% year over year.
Uber (UBER) reports Q4 2025 earnings on February 4, 2026, with consensus estimates of $0.78 EPS and $14.32 billion in revenue, up about 20% year over year.
Qualcomm’s Q1 FY2026 report, covering the period ended December 28, 2025, arrives amid a pivotal shift in the semiconductor landscape. While handset growth moderates, the company is expanding in automotive, IoT, and AI-enabled devices.
UBS Group AG reports Q4 2025 earnings on February 4, 2026, with consensus EPS ranging $0.25–$0.67 and revenue around $11.62 billion, down YoY. HSBC Holdings plc reports Q4 earnings on February 25, 2026, with consensus EPS ~$1.57; Q3 showed resilient net interest income despite $1.4B in legal provisions.
Boston Scientific’s Q4 caps a transformative year, driven by ~15.5% organic growth from WATCHMAN, FARAPULSE electrophysiology, and MedSurg expansions. As a leader in minimally invasive devices, BSX’s results set the benchmark against Medtronic and Stryker—diversified medtech giants navigating tariffs, procedural rebounds, and innovation.
Arm, the leading provider of energy-efficient processor designs powering over 99% of smartphones and expanding into AI data centers, faces high scrutiny in Q3 FY2026 (ending Dec 31, 2025). After a strong Q2 with record royalty and licensing revenue, investors are focused on whether AI demand will continue to drive robust growth.
Datadog (DDOG) has come under pressure in recent sessions as volatility across the software sector weighs on sentiment ahead of earnings. Trading in the $108–120 range following a pullback from highs near $200, the stock reflects a disconnect between near-term market caution and resilient underlying fundamentals.
Starbucks shares have shown renewed strength in recent trading, rebounding from earlier lows within a 52-week range of $75.50 to $117.46. The recovery reflects improving comparable sales trends and a return to transaction growth, suggesting early progress from operational initiatives aimed at reconnecting with customers.
DoorDash holds a Strong Buy consensus from 33 analysts, with an average 12-month price target of $280.82, implying more than 40% upside from recent trading levels.
Amazon’s Q4 report capped a strong year marked by accelerating cloud growth, steady retail execution, and expanding advertising profitability. The results reinforced Amazon’s positioning as a core beneficiary of enterprise AI demand, particularly through AWS, while highlighting improving operating leverage across the broader business.
ConocoPhillips reported Q4 2025 adjusted EPS of $1.02, below consensus of $1.08, driven by weaker realized commodity prices.
ICE reported Q4 2025 net revenues of $2.5 billion, up 8% year-over-year, capping 20 consecutive years of record annual revenues at $9.9 billion.
Eli Lilly’s Q4 results highlight explosive growth from GLP-1 therapies, cementing leadership in obesity and diabetes. The company’s strong revenue beat and robust 2026 guidance illustrate high-growth pharma dynamics. Johnson & Johnson, in contrast, exemplifies a diversified healthcare strategy, combining pharmaceuticals, MedTech, and consumer health for steady expansion.
Eli Lilly (LLY), AbbVie (ABBV), and Merck (MRK) all reported strong Q4 2025 earnings, but the market reacted differently to each, reflecting variations in growth profiles, product concentration, and sector dynamics. AbbVie delivered Q4 revenue of $16.62 billion, up 10% year-over-year, with full-year revenue reaching $61.2 billion, an 8.6% increase. Adjusted EPS came in at $2.71, surpassing consensus, though shares dipped following the report amid ongoing Humira concerns
Novo Nordisk (NVO) reported Q4 2025 EPS of $1.02, surpassing estimates of $0.92, with revenue of $12.53B vs $11.99B expected. Full-year 2025 sales rose 10% at constant exchange rates (CER) to DKK 309B, but 2026 guidance anticipates a 5–13% decline at CER due to pricing pressures. Novartis (NVS) posted Q4 core EPS of $2.03, beating $1.99 estimates; net sales of $13.34B slightly missed consensus. FY sales grew 8%, with core EPS up 17% to $8.98.
MUFG (Mitsubishi UFJ Financial Group) posted Q3 FY2026 profits of ¥1.81 trillion, up 3.7% YoY, on track for its full-year target of ¥2.1 trillion. HSBC is set to report Q4 FY2025 earnings on Feb 25, 2026, with consensus EPS around $1.60; recent quarters showed resilient net interest income (NII) supported by Asia wealth growth.
Gogo shares continue to trade near 52-week lows around $4, weighed down by competitive threats from Starlink and slower-than-anticipated AVANCE system upgrades. William Blair downgraded the stock to Market Perform in December 2025, citing leverage concerns and intensifying rivalry in in-flight connectivity.
Quantum Computing Inc. completed a $110 million acquisition of Luminar Semiconductor on February 2, significantly strengthening its photonics and manufacturing capabilities. Shares have traded with elevated volatility, peaking near $12.70 in mid-January before retreating to the $9 range amid heavy volume.
ERII shares have remained resilient, trading near $15.47 ahead of Q4 and full-year 2025 earnings scheduled for February 25, 2026. Q3 2025 results exceeded expectations, with revenue of $32 million and EPS of $0.07, despite year-over-year declines tied to project timing.